Capecitabine and the Risk of Fingerprint Loss-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Capecitabine and the Risk of Fingerprint Loss

Published:2017-01-01 Issue:1 Volume:3 Page:122
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

van Doorn Leni¹,Veelenturf Sebastiaan²,Binkhorst Lisette³,Bins Sander¹,Mathijssen Ron¹

Affiliation:

1. Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands

2. Regional Criminal Investigations Division, National Police, The Hague, the Netherlands

3. Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands3Apotheek Haagse Ziekenhuizen/HagaZiekenhuis, The Hague, the Netherlands

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous Manifestation of Chemotherapeutic Agents;Complications of Cancer Therapy: Best Practices in Prevention and Management;2024

2. Overview of Cancer Drugs That Cause Fingerprint Loss;Doğu Karadeniz Sağlık Bilimleri Dergisi;2023-11-30

3. Capecitabine induces hand-foot syndrome through elevated thymidine phosphorylase-mediated locoregional toxicity and GSDME-driven pyroptosis that can be relieved by tipiracil;British Journal of Cancer;2022-11-08

4. Drugs and the skin: A concise review of cutaneous adverse drug reactions;British Journal of Clinical Pharmacology;2022-08-29

5. Deducing health cues from biometric data;Computer Vision and Image Understanding;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP